Sarasota, FL, United States of America

Erkan Riza

This inventor holds 10 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Cirkul, Inc., Faro Technologies, Inc., Apollo Renal Therapeutics, LLC. Active years: 2015-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erkan Riza. Retrieved from https://idiyas.com/inventor/erkan-riza

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 10 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.6

ph-index = 6

Forward Citations = 144(Granted Patents)


Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Inventor Erkan Riza: Pioneering Innovations in Sarasota

Introduction: Erkan Riza is a visionary inventor based in Sarasota, FL, known for his groundbreaking contributions to various technological fields.

Latest Patents: Erkan Riza holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Erkan Riza has consistently pushed the boundaries of technology, leading to the development of cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Erkan Riza has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life, fostering a culture of innovation and collaboration.

Conclusion: Erkan Riza's passion for innovation and his relentless drive to create a positive impact on society make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…